10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives combined

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 34, 435 18, 435 29, 435 39, 435 40, 435 51, 536 72, A61K 3170, C07H 1708

Patent

active

056417535

ABSTRACT:
Pharmaceutical compositions of an erythromycin derivative combined with sulfisoxazole according to the structural formulas: ##STR1## where R is hydrogen, C1-C10 alkylcarbonyl or C1-C10 alkyl wherein the substituent is amino or cyano; R1 and R2 are independently hydrogen, hydroxyl or amino; and the pharmaceutical salts and esters thereof.

REFERENCES:
Tarpay et al., Antimicrobial Agents and Chemotherapy, vol. 22, No. 1, pp. 145-147 (1982).
Hughes et al., J. of Infectious Diseases, vol. 170, No. 1, pp. 906-911, (1994).
Doern et al., Antimicrobial Agents and Chemotherapy, vol. 32, No. 2, pp. 180-185 (1988).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives combined does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives combined , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives combined will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-149176

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.